PortfoliosLab logo

Anika Therapeutics, Inc. (ANIK)

Equity · Currency in USD · Last updated Apr 1, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Anika Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $82,057 for a total return of roughly 720.57%. All prices are adjusted for splits and dividends.


600.00%650.00%700.00%750.00%800.00%850.00%NovemberDecember2023FebruaryMarch
720.57%
849.96%
ANIK (Anika Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ANIK

Anika Therapeutics, Inc.

Return

Anika Therapeutics, Inc. had a return of -2.97% year-to-date (YTD) and 13.83% in the last 12 months. Over the past 10 years, Anika Therapeutics, Inc. had an annualized return of 7.01%, while the S&P 500 had an annualized return of 10.16%, indicating that Anika Therapeutics, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-9.40%3.51%
Year-To-Date-2.97%7.03%
6 months22.68%12.88%
1 year13.83%-10.71%
5 years (annualized)-10.40%9.25%
10 years (annualized)7.01%10.16%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20234.76%2.23%
20225.31%19.41%10.98%-6.15%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Anika Therapeutics, Inc. Sharpe ratio is 0.33. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.00NovemberDecember2023FebruaryMarch
0.33
-0.46
ANIK (Anika Therapeutics, Inc.)
Benchmark (^GSPC)

Dividend History


Anika Therapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%NovemberDecember2023FebruaryMarch
-60.85%
-14.33%
ANIK (Anika Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Anika Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Anika Therapeutics, Inc. is 95.88%, recorded on Dec 26, 2000. It took 1642 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.88%Jul 15, 1998620Dec 26, 20001642Jul 25, 20072262
-86.24%Sep 24, 2007321Dec 30, 20081154Aug 1, 20131475
-72.19%Oct 28, 2019638May 9, 2022
-68.42%May 13, 1993395Dec 16, 1994336May 3, 1996731
-57.96%Jan 30, 201899Jun 20, 2018340Oct 25, 2019439
-54.92%May 20, 1996144Dec 17, 1996174Aug 28, 1997318
-37.83%Jul 15, 2014306Sep 29, 2015185Jun 23, 2016491
-30.95%Dec 11, 199734Jan 30, 199847Apr 8, 199881
-24.37%Jan 17, 201411Feb 3, 201416Feb 26, 201427
-23.63%Jul 5, 201687Nov 3, 2016210Sep 6, 2017297

Volatility Chart

Current Anika Therapeutics, Inc. volatility is 28.11%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%NovemberDecember2023FebruaryMarch
28.11%
15.42%
ANIK (Anika Therapeutics, Inc.)
Benchmark (^GSPC)